Chapter 1: Photobiology and Circadian Medicine

Chapter Introduction

The Rooster has crowed with you a long way.

In K-12 you met the light — that you need outdoor light in the morning to anchor your day, that your eyes have receptors beyond rods and cones for telling time, that screens at night confuse your sleep clock. At Associates you went into chronobiology proper — the suprachiasmatic nucleus as the master pacemaker, the BMAL1/CLOCK/PER/CRY transcription-translation feedback loop in survey, the phase response curve concept, Rosenthal's 1984 discovery of seasonal affective disorder and the bright-light therapy that followed, and the integrator move that named light as synchronizer — the entrainment signal, the only one of the ten positions grounded in external timing input rather than internal regulatory function.

This chapter is the eighth step of the upper-division spiral.

At the Bachelor's level, Coach Light goes receptor-deep, gene-expression-deep, and clinically deep. Where Associates said ipRGCs use melanopsin to signal the SCN, Bachelor's enters David Berson's 2002 PNAS discovery paper on intrinsically photosensitive retinal ganglion cells at full molecular depth (parallel to the McKemy/Patapoutian TRPM8 and Caterina/Julius TRPV1 receptor-discovery anchors in Cold and Hot Bachelor's — three sensory-modality molecular paradigm shifts in a five-year window). Where Associates introduced the molecular clock, Bachelor's walks the BMAL1/CLOCK/PER/CRY transcription-translation feedback loop at gene-regulation resolution, the 2017 Nobel lineage from Konopka and Benzer's 1971 period mutant discovery in Drosophila through Hardin, Hall, and Rosbash's 1990 Nature discovery of the negative feedback loop to Young's timeless and doubletime contributions, with post-translational modifications (casein kinase 1 phosphorylation, FBXL3 ubiquitination of CRY) fine-tuning period. Where Associates introduced the phase response curve, Bachelor's enters the Khalsa et al. 2003 Journal of Physiology paper at intervention-trial depth and the clinical chronotherapy framework that follows.

The voice is the same Rooster. Dawn herald. Timekeeper. Practical. No-nonsense. What changes is the molecular and clinical depth. Photobiology is one of the more elegant systems in mammalian biology — a small set of photoreceptors translating photon energy into neural signals, a master clock in 20,000 hypothalamic neurons coordinating body-wide oscillations, and a hormonal system (the vitamin D axis) that connects skin, liver, and kidney into an endocrine cascade with consequences across bone, immunity, and beyond.

A word about safety, before you begin. The chapter never recommends direct sun-gazing. Real retinal damage occurs from direct solar viewing; the wellness-industry shorthand "view the sun" is reframed throughout as "morning outdoor light exposure with appropriate eye care." Tanning beds are not in this chapter — the skin cancer risk is established, and any "tanning bed for vitamin D" framing is rejected. Vitamin D supplementation is presented descriptively at biochemistry depth; specific supplementation decisions belong in clinical conversation. Light therapy for seasonal affective disorder is presented as published clinical research in adults under medical guidance — never as self-treatment for kids or clinically untreated depression.

A word about the modern light environment, before you begin. The chapter is honest about the population health consequences of indoor light-dominated lifestyles, shift work, and chronic circadian misalignment. The Rosenberg, Roenneberg, and Wright research traditions document real effects. The wellness-industry framing of "circadian medicine" often expands beyond what the research supports; the chapter teaches the actual research and the methodological discipline to distinguish it from overclaim.

This chapter has five lessons.

Lesson 1 is Photobiology at Molecular Receptor Depth — visible light physics and photon energy, rhodopsin and cone opsins for image-forming vision, melanopsin and intrinsically photosensitive retinal ganglion cells (Berson 2002 foundational anchor), M1-M5 ipRGC subtypes with distinct projections, the bistable melanopsin photopigment, and the ~480 nm wavelength sensitivity peak.

Lesson 2 is Molecular Clock Machinery at Gene Expression Resolution — BMAL1/CLOCK/PER/CRY transcription-translation feedback loop at gene-regulation depth, peripheral clocks and the SCN hierarchy, the 2017 Nobel lineage from Konopka-Benzer 1971 through Hardin-Hall-Rosbash 1990 to Young's TIM/DBT contributions, post-translational modifications fine-tuning period. Cross-references Sleep Bachelor's Lesson 2 at lesson-level resolution — same TTFL biology from photic-entrainment angle.

Lesson 3 is Phase Response Curves and Clinical Chronotherapy — the human PRC to light at Khalsa et al. 2003 Journal of Physiology depth, Chang et al. 2015 PNAS evening blue light melatonin suppression, IARC 2007 shift work as Group 2A "probably carcinogenic" with 2019 reaffirmation at full methodology depth, jet lag chronotherapy.

Lesson 4 is Vitamin D Biochemistry and Bone Health — cutaneous 7-DHC photoisomerization, hepatic CYP2R1 25-hydroxylation, renal CYP27B1 1α-hydroxylation, VDR as nuclear hormone receptor with RXR heterodimerization, calcium and phosphate homeostasis cascade, the latitude/season/skin-pigmentation/age variables, the IOM 2011 versus Endocrine Society sufficiency threshold debate, VITAL trial null findings honestly cited.

Lesson 5 is Light Therapy Clinical Research and Modern Light Environment Pathophysiology — Rosenthal et al. 1984 SAD discovery, subsequent bright-light therapy RCT literature, Wright et al. camping studies on natural-light SCN entrainment, Roenneberg social jet lag epidemiology, IARC night-shift classification revisited, and the five-point framework applied to "circadian medicine" claims.

The Rooster is in no hurry. Dawn comes when it comes. Begin.

---

Lesson 1: Photobiology at Molecular Receptor Depth

Learning Objectives

By the end of this lesson, you will be able to:

• Describe visible light physics at the level of photon energy, wavelength, and the spectral composition of natural and artificial light sources
• Identify rhodopsin and cone opsins as the principal photoreceptor classes for image-forming vision and describe their molecular architecture
• Describe melanopsin and intrinsically photosensitive retinal ganglion cells (ipRGCs) — identify the Berson, Dunn, Takao 2002 PNAS discovery paper as foundational
• Distinguish M1 through M5 ipRGC subtypes by projection target and functional role
• Describe the bistable melanopsin photopigment and articulate how its photochemistry differs from mammalian rod/cone opsins
• Identify the ~480 nm wavelength sensitivity peak of melanopsin and its relevance to circadian biology

Key Terms

Visible Light Physics at Thermodynamic Resolution

Light is electromagnetic radiation. The visible spectrum spans wavelengths from approximately 380 nm (violet) to 780 nm (red); shorter wavelengths are ultraviolet (with biological consequences for vitamin D synthesis and DNA damage), longer wavelengths are infrared (with thermal effects). Each photon carries energy inversely proportional to wavelength: E = hc/λ, where h is Planck's constant and c is the speed of light. Shorter wavelength photons (violet, blue) carry more energy per photon than longer wavelength photons (red, infrared).

The biological consequences of the energy-wavelength relationship matter substantially [1]:

• Ultraviolet (UVB, 280-315 nm) — High-energy photons; capable of producing photochemistry in skin (vitamin D synthesis, DNA dimer formation) and ocular damage.
• Visible short-wavelength (blue, ~440-480 nm) — Sufficient energy for melanopsin phototransduction (the ipRGC peak); also produces some retinal photochemistry and is the wavelength range implicated in the evening blue light / melatonin suppression literature.
• Visible long-wavelength (red, ~625-700 nm) — Lower photon energy; limited circadian effects through melanopsin; "red-shifted" lighting at night minimizes melanopsin activation.
• Infrared (>780 nm) — Insufficient photon energy for most photochemistry; principal biological effect is thermal.

Natural sunlight contains a broad spectrum from UV through visible into infrared. Indoor lighting historically (incandescent) contained more long-wavelength content; modern LED lighting contains more short-wavelength content, with implications for evening light exposure and circadian entrainment that Lesson 3 covers.

Rhodopsin and Cone Opsins for Image-Forming Vision

The classical mammalian photoreceptors — rods and cones — support image-forming vision. The molecular machinery is one of the best-characterized in cellular biology [2][3]:

Rhodopsin — The rod photopigment. Approximately 100 million rods per human retina, distributed predominantly in the peripheral retina. Rhodopsin consists of the protein opsin (a seven-transmembrane G-protein-coupled receptor) covalently bound to 11-cis-retinal (a vitamin A aldehyde derivative). The molecular cycle:

1. Photon absorption isomerizes 11-cis-retinal to all-trans-retinal, activating opsin (forming metarhodopsin II).
2. Activated opsin catalyzes GDP-to-GTP exchange on the G-protein transducin (Gt).
3. Activated transducin α-subunit activates cyclic GMP phosphodiesterase (PDE), hydrolyzing cytoplasmic cGMP.
4. Lowered cGMP closes cyclic nucleotide-gated (CNG) channels in the plasma membrane.
5. Closure reduces inward Na⁺ and Ca²⁺ current; the cell hyperpolarizes (the opposite direction from typical neuronal response).
6. Hyperpolarization reduces glutamate release at the synapse with bipolar cells, signaling photon absorption to downstream circuits.

The cascade has remarkable amplification — a single photon can produce a measurable cellular response, supporting vision at the limit of single-photon detection. Recovery involves rhodopsin phosphorylation (rhodopsin kinase), arrestin binding, all-trans-retinal release and recycling, and cGMP resynthesis.

Cone opsins — The cone photopigments. Approximately 6 million cones per human retina, concentrated in the fovea. Three types support color vision:

• S-cone (short-wavelength sensitive) — Peak sensitivity ~420 nm (violet-blue); SWS1 opsin gene on chromosome 7.
• M-cone (medium-wavelength sensitive) — Peak ~530 nm (green); OPN1MW gene on X chromosome.
• L-cone (long-wavelength sensitive) — Peak ~560 nm (red-orange); OPN1LW gene on X chromosome adjacent to OPN1MW.

The phototransduction cascade in cones is similar to that in rods but with cone-specific isoforms of several components, supporting faster kinetics and brighter operating range. Color vision emerges from comparison of activation patterns across the three cone classes in cortical visual processing.

The classical model of vision through the 20th century: rods and cones detect photons; bipolar, horizontal, amacrine, and ganglion cells process the signals; the optic nerve carries the output to lateral geniculate nucleus and visual cortex. This image-forming pathway remains the principal substrate of vision in mammals.

What changed at the start of the 21st century is the recognition that retinal ganglion cells themselves can be photoreceptors, with profound consequences for circadian biology.

The Berson 2002 Discovery of ipRGCs

The foundational anchor for this chapter is the 2002 paper by David Berson, Felice Dunn, and Motoharu Takao in PNAS: Phototransduction by retinal ganglion cells that set the circadian clock [4]. The discovery moment of mammalian intrinsically photosensitive retinal ganglion cells (ipRGCs) and the molecular foundation of non-image-forming photoreception.

The findings:

• A subset of retinal ganglion cells respond to light directly, even when synaptic input from rods and cones is pharmacologically blocked.
• The photoreceptor pigment driving this intrinsic phototransduction is melanopsin (encoded by the OPN4 gene, identified earlier by Provencio and colleagues).
• These ipRGCs project to the suprachiasmatic nucleus (the master circadian pacemaker), providing the molecular substrate for the long-recognized but unexplained ability of light to entrain mammalian circadian rhythms.

The Berson discovery answered a decades-old question. Rod and cone genetic ablation studies had shown that mice without rods and cones still entrained their circadian rhythms to light cycles — but the photoreceptor responsible was unknown. The ipRGC discovery identified the missing photoreceptor class and revealed that the mammalian retina has two photoreceptive systems: the classical image-forming system (rods, cones, transmitted through bipolar and ganglion cells to lateral geniculate and visual cortex) and the non-image-forming system (ipRGCs with their own melanopsin photopigment, projecting to SCN, olivary pretectal nucleus, and other non-image-forming targets).

The parallel to other 21st-century receptor-discovery foundational moments is intentional. McKemy and colleagues identified TRPM8 (the cold receptor) in 2002 (cited in Cold Bachelor's Lesson 1, Patapoutian Nobel 2021). Caterina and colleagues identified TRPV1 (the heat receptor) in 1997 (cited in Hot Bachelor's Lesson 1, Julius Nobel 2021). Berson and colleagues identified ipRGCs in 2002 (cited here). Three sensory modalities, three molecular paradigm shifts in a five-year window. Modern sensory neuroscience operates on the foundations these papers established.

M1-M5 ipRGC Subtypes and Their Projections

Subsequent research, led principally by Samer Hattar and colleagues, has identified five ipRGC subtypes with distinct morphology, electrophysiology, and projection targets [5][6][7]:

M1 ipRGCs — Dendrites stratifying in the outer plexiform layer (ON sublamina). Highest melanopsin expression. Slowest spike rate, most sustained response. Principal projection: suprachiasmatic nucleus (circadian entrainment) and olivary pretectal nucleus (pupillary light reflex). The M1 subtype is the canonical circadian/pupillary ipRGC.

M2 ipRGCs — Dendrites in the inner plexiform layer (OFF sublamina). Less melanopsin than M1. Project to olivary pretectal nucleus, intergeniculate leaflet, and other targets. Contribute to pupillary reflex and circadian function.

M3 ipRGCs — Bistratified (dendrites in both ON and OFF sublaminae). Less well-characterized; smaller population.

M4 ipRGCs — High proportion of ON alpha-like ganglion cells with melanopsin expression. Project to dorsal lateral geniculate nucleus and contribute to image-forming vision (a notable revision of the original "ipRGCs are non-image-forming only" framing). M4 cells appear to support visual contrast sensitivity at low photopic levels.

M5 ipRGCs — Most recently characterized. Bistratified, narrow dendritic field, primate-specific in some characterizations; project to dLGN and may contribute to color vision properties.

The diversity of ipRGC subtypes has reshaped the field's understanding of retinal photoreception. The simple "image-forming versus non-image-forming" dichotomy is partly replaced by a more nuanced architecture: M1 ipRGCs are predominantly non-image-forming (circadian, pupillary); M4 and M5 contribute to image-forming vision through novel pathways; M2 and M3 occupy intermediate roles. The integration of intrinsic photoreception with rod/cone synaptic input produces a richer signaling architecture than either alone.

For pre-clinical students moving toward ophthalmology, neurology, or vision science: the ipRGC subtype framework is contemporary core knowledge. The clinical implications include understanding of pupillary light reflex testing (M1 ipRGC function can be assessed by sustained pupillary response to bright blue light, distinct from rod/cone-driven responses), of seasonal mood disorders (M1 ipRGC SCN drive is the principal substrate of light therapy), and of certain retinopathies where rod/cone-dominant disease leaves ipRGC function relatively preserved.

The Bistable Melanopsin Photopigment

Melanopsin has a distinctive photochemistry that distinguishes it from mammalian rod/cone opsins [8][9]:

Bistability — Melanopsin has two stable conformational states. The dark state (with 11-cis-retinal) is converted by absorption of a "shorter-wavelength" photon (~480 nm peak) to an active signaling state (with all-trans-retinal). Unlike rod/cone opsins, however, the active state of melanopsin is itself photosensitive — absorption of a "longer-wavelength" photon (~590 nm peak) can convert it back to the dark state without requiring enzymatic regeneration.

The bistable architecture has consequences:

• Continuous photoreception — Melanopsin can continue to signal under sustained bright light without the "bleaching" that takes rod/cone opsins out of service after intense exposure.
• Spectral integration — The net signaling depends on both short-wavelength activation and longer-wavelength deactivation; the steady-state activation level reflects the photon flux ratio across the spectrum.
• Slow kinetics — Melanopsin phototransduction is slower than rod/cone phototransduction (seconds to minutes for full activation versus milliseconds), consistent with its role in steady-state environmental light sensing rather than image-forming photon-by-photon detection.

The bistability is a feature shared with invertebrate visual pigments (rhabdomeric photoreceptors). Mammalian melanopsin retains this ancient pigment architecture, distinct from the ciliary rod/cone opsins. The evolutionary lineage and pharmacology of melanopsin connect mammalian non-image-forming photoreception to broader invertebrate visual biology — one of the more intriguing molecular continuities across major animal lineages.

Wavelength Sensitivity and the 480 nm Peak

Melanopsin's peak sensitivity in the ~480 nm range (blue-cyan portion of the spectrum) has substantial implications for chronobiology and circadian-relevant light environments. The 480 nm peak determines:

• Natural daylight is highly effective for ipRGC activation — Solar spectrum contains substantial 480 nm content; outdoor light, even on overcast days, robustly activates the ipRGC system.
• Indoor light is less effective by orders of magnitude — Typical indoor electric light is dim (typically 100-500 lux versus outdoor 10,000-100,000 lux) and often shifted toward longer wavelengths.
• Evening blue light from screens activates ipRGCs — LED-illuminated screens (computers, phones, televisions) emit substantial 480 nm content; viewing in the evening produces measurable ipRGC activation, melatonin suppression, and circadian phase delays under controlled conditions (Lesson 3 returns to this with the Chang 2015 PNAS paper at full methodology).
• Spectrally targeted lighting — Both research (lab studies of light effects) and consumer products (blue-light filters, blue-blocking glasses, red-shifted evening lighting) attempt to manipulate ipRGC activation through spectral content.

The Bachelor's-level reading discipline: the 480 nm peak is real and biologically consequential; the wellness-industry framing of "blue light" effects often expands beyond what controlled research supports, particularly for consumer products that don't replicate laboratory exposure conditions.

Lesson Check

1. Describe rhodopsin phototransduction from photon absorption through membrane hyperpolarization. Identify the role of transducin, PDE, and cGMP in the cascade.
2. Distinguish the three cone opsin types (S, M, L) by wavelength sensitivity and chromosomal location.
3. Identify David Berson's 2002 PNAS paper as foundational. What did the paper demonstrate about retinal photoreception that the classical rod/cone framework could not explain?
4. Describe the five ipRGC subtypes (M1-M5) and identify the principal projection target and functional role of each.
5. Walk the bistable melanopsin photopigment. Why does it differ from rod/cone opsins, and what consequences follow for circadian-relevant photoreception?
6. Articulate why the ~480 nm peak of melanopsin matters for the contemporary indoor/outdoor light environment and for evening screen exposure.

---

Lesson 2: Molecular Clock Machinery at Gene Expression Resolution

Learning Objectives

By the end of this lesson, you will be able to:

• Walk the BMAL1/CLOCK/PER/CRY transcription-translation feedback loop at gene regulation resolution
• Trace the historical lineage from Konopka and Benzer's 1971 period mutant discovery in Drosophila through Hardin, Hall, and Rosbash's 1990 Nature discovery of the negative feedback loop to the 2017 Nobel Prize
• Describe peripheral clocks throughout the body and the SCN-to-peripheral hierarchy
• Identify food entrainment of peripheral clocks (Damiola 2000 cited in Sleep Bachelor's, re-cited here)
• Describe post-translational modifications fine-tuning clock period (casein kinase 1 phosphorylation, FBXL3 ubiquitination of CRY)
• Apply the lateral to Sleep Bachelor's Lesson 2 covering the same biology from the sleep-regulation angle

Key Terms

The Molecular Clock as Foundational Biology

The molecular clock is one of the most elegantly conserved biological mechanisms across the eukaryotic kingdom. From cyanobacteria to fungi to plants to insects to mammals, organisms maintain ~24-hour periods through autoregulatory transcription-translation feedback loops with broadly homologous architectures (though the specific gene products vary across phyla). The contemporary mammalian molecular clock has been worked out at substantial molecular detail [10][11].

The Sleep Bachelor's Lesson 2 chapter walked the same TTFL machinery from the sleep-regulation angle. This chapter covers the same biology from the photic-entrainment angle, with attention to the historical lineage that produced the 2017 Nobel Prize in Physiology or Medicine.

The Historical Lineage: Konopka-Benzer 1971 to the 2017 Nobel

The molecular biology of circadian clocks has a clean historical lineage that pre-clinical students benefit from knowing.

Konopka and Benzer 1971 — Ronald Konopka, working in Seymour Benzer's laboratory at Caltech, identified the first circadian-rhythm mutants in Drosophila melanogaster. By chemical mutagenesis and behavioral screening of fly emergence and locomotor activity, Konopka identified three mutants at a single locus producing short-period, long-period, and arrhythmic phenotypes. The locus was named period (per). The 1971 PNAS paper Clock mutants of Drosophila melanogaster established that circadian rhythms are encoded by specific genes accessible to molecular-genetic analysis [12]. The discovery moment of molecular chronobiology.

Hardin, Hall, Rosbash 1990 — Almost two decades after Konopka and Benzer, Paul Hardin, Jeffrey Hall, and Michael Rosbash at Brandeis demonstrated in Nature that period mRNA and PER protein levels oscillate with circadian period, with PER protein peaks following mRNA peaks by a delay, and showed that PER protein feeds back to inhibit its own gene transcription [13]. The paper established the negative feedback loop architecture that became the conceptual template for understanding clock molecular biology across species. The discovery transformed clock biology from genetic identification of mutants to mechanistic understanding of how a 24-hour oscillator is built from molecular components.

Sehgal, Young, and the discovery of timeless — In the early 1990s, Amita Sehgal in Michael Young's laboratory identified timeless (tim) — a second clock gene encoding a protein (TIM) that interacts with PER and is required for normal circadian oscillation. The PER-TIM interaction was for years the dominant model of Drosophila clock architecture.

Young's doubletime and post-translational regulation — Michael Young's group identified doubletime (dbt), encoding a casein kinase 1 (CK1) ortholog. DBT phosphorylates PER, regulating its stability and nuclear entry. The discovery established post-translational modification as a key layer of clock regulation [14].

Mammalian clock-gene cloning — Through the 1990s and early 2000s, mammalian orthologs and additional clock components were cloned: mouse Clock gene (Vitaterna and Takahashi 1994); Bmal1 (also called Arntl); three mammalian Per genes (Per1, Per2, Per3); two Cryptochrome (Cry) genes that supplanted timeless as the principal PER partners in mammals. The contemporary mammalian molecular clock architecture emerged from this work [15][16].

The 2017 Nobel Prize — Jeffrey Hall, Michael Rosbash, and Michael Young shared the 2017 Nobel Prize in Physiology or Medicine for their discoveries of molecular mechanisms controlling the circadian rhythm. The Nobel recognized the foundational period-gene work, the negative feedback loop discovery, and the subsequent elaboration of clock-gene architecture [17].

The Mammalian TTFL at Gene Regulation Depth

The contemporary mammalian molecular clock operates through a transcription-translation feedback loop (TTFL) in which clock-gene proteins negatively regulate their own transcription. The canonical loop [18][19]:

1. BMAL1 and CLOCK form a heterodimer. Both are bHLH-PAS transcription factors. The heterodimer binds E-box DNA sites (consensus sequence CACGTG) in target gene promoters.
2. BMAL1/CLOCK drives transcription of Per (Per1, Per2, Per3) and Cry (Cry1, Cry2) genes. The transcription factor also drives expression of hundreds of clock-controlled genes (CCGs) including Rev-erbα, Rorα/β/γ, Dbp, and many tissue-specific targets that produce the cellular oscillations of physiology, metabolism, and behavior.
3. PER and CRY proteins accumulate in cytoplasm. The proteins form complexes with each other and with kinases (CK1ε and CK1δ, the mammalian descendants of Drosophila DBT, phosphorylating PER and regulating its stability and nuclear entry).
4. PER/CRY complexes translocate to the nucleus. CRY directly binds BMAL1/CLOCK and inhibits its transcriptional activity. This is the negative feedback arm of the loop.
5. With BMAL1/CLOCK inhibited, Per and Cry transcription falls. The existing PER and CRY proteins are progressively degraded through ubiquitin-proteasome pathways. CRY degradation is regulated by FBXL3, an F-box protein recruiting CRY to the SCF E3 ubiquitin ligase complex. FBXL3 mutations (after hours) substantially lengthen the clock period in mice — one of several molecular handles affecting clock period that has been worked out at substantial detail [20][21].
6. As PER and CRY are cleared, BMAL1/CLOCK regains transcriptional activity. The cycle repeats.

The full cycle takes approximately 24 hours under controlled cellular conditions. The kinetic features that produce a near-24-hour period include the delay between transcription and translation, PER/CRY protein accumulation and complex-formation kinetics, nuclear translocation timing, phosphorylation-regulated PER stability (CK1 phosphorylation), and ubiquitin-mediated CRY degradation rate (FBXL3-dependent).

Secondary feedback loop — BMAL1/CLOCK drives transcription of Rev-erbα and Rorα/β/γ, which in turn regulate BMAL1 transcription. Rev-erbα represses Bmal1; Rorα/β/γ activate it. The secondary loop adds robustness and supports precise period control. The architecture is sometimes described as interlocking transcriptional feedback loops rather than a single loop, with multiple regulatory nodes producing the integrated oscillation.

The SCN as Master Pacemaker

The suprachiasmatic nucleus (SCN) — approximately 20,000 neurons in the anterior hypothalamus above the optic chiasm — is the principal mammalian master pacemaker. Sleep Bachelor's Lesson 2 covered the SCN at the level of cellular oscillation, network coupling, and light entrainment. From the photic-entrainment angle:

Retinohypothalamic projection — ipRGCs (Lesson 1) project directly to the SCN, providing the principal photic input. The projection is bilateral; both SCN nuclei receive ipRGC input. Glutamate is the principal neurotransmitter; PACAP (pituitary adenylate cyclase-activating peptide) is co-released and contributes to phase shifting.

Phase-shifting at molecular level — Light input to SCN at appropriate phases of the circadian cycle produces phase shifts (Lesson 3 returns to the PRC). The molecular mechanism involves induction of Per1 and Per2 expression by the photic input — phasic ipRGC firing at SCN activates glutamatergic signaling, calcium entry, CREB phosphorylation, and transcription of Per genes. The phase-dependent effect arises because adding Per expression at different points in the cycle produces different consequences for the existing oscillation: phase advance (if added on the rising phase) or phase delay (if added on the falling phase) [22].

SCN intrinsic period — Human SCN intrinsic period is approximately 24.18 hours under controlled forced-desynchrony conditions (Czeisler and colleagues' work, cited in Sleep Bachelor's Lesson 2). The intrinsic period is slightly longer than the solar day, requiring daily light input to entrain to 24 hours. Without daily light input (in laboratory time-isolation studies), human circadian rhythms drift later by approximately 11 minutes per day on average.

Peripheral Clocks and the SCN-Peripheral Hierarchy

Beyond the SCN, cell-autonomous TTFL oscillators exist in essentially every tissue. Sleep Bachelor's Lesson 2 covered this hierarchy and the Damiola et al. 2000 finding that food timing can entrain peripheral clocks independently of the SCN. The complementary perspective from the photic-entrainment side:

• Under normal conditions — Light entrains the SCN, which through autonomic, hormonal (melatonin), and behavioral outputs synchronizes peripheral clocks to the same phase.
• Under disrupted conditions — Shift work, jet lag, or chronic late eating can produce internal desynchrony between SCN and peripheral clocks. The SCN responds to light; peripheral clocks (particularly hepatic) respond to food. When light and food schedules conflict, the clocks dissociate.
• Clinical consequences — Chronic internal desynchrony has been implicated in cardiometabolic disease, gastrointestinal dysfunction, immune effects, and mood disorders. The mechanisms are still being characterized; the clinical translation is at intermediate stages [23][24].

The contemporary "chronobiology" framework integrates the SCN-peripheral hierarchy with chronotype (Roenneberg's work), social jet lag, and the broader population health implications of modern indoor light-and-irregular-meal environments. The framework is well-grounded in molecular biology; the wellness-industry "circadian medicine" framings often borrow from this research but may exceed what controlled research supports — a discipline Lesson 5 returns to.

Cross-Reference to Sleep Bachelor's Lesson 2: Same Biology, Different Angle

Sleep Bachelor's Lesson 2 walked the same BMAL1/CLOCK/PER/CRY machinery from the sleep-regulation angle: how the molecular clock organizes sleep timing, how chronotype variation arises from clock-gene polymorphisms, how peripheral clock entrainment by food integrates with sleep-wake cycles.

Light Bachelor's Lesson 2 walks the same machinery from the photic-entrainment angle: how ipRGCs deliver light information to the SCN, how the SCN molecular clock processes this information through phase shifts and entrainment, how the SCN-peripheral clock hierarchy operates.

The complementary perspectives are characteristic of upper-division biology: the same molecular system can be approached from multiple angles depending on which functional question is being asked. The Bachelor's-level reading discipline includes recognizing when a paper or framework is approaching shared biology from a particular angle and being able to integrate across angles.

For pre-clinical students, the integration matters clinically. A patient with insomnia and a particular chronotype, working night shifts, with metabolic syndrome — has dysregulation that operates simultaneously at the photic-entrainment level (light environment mismatched to physiological need), the molecular clock level (intrinsic chronotype not matched to imposed schedule), the SCN-peripheral hierarchy level (light-driven SCN versus food-driven peripheral clocks), and the downstream pathophysiology level. Clinical management requires recognizing the integration across all levels.

Lesson Check

1. Walk the BMAL1/CLOCK/PER/CRY TTFL at gene regulation depth. Identify E-box sites, CRY-CLOCK inhibition, and the kinetic features producing the ~24-hour period.
2. Trace the historical lineage from Konopka-Benzer 1971 through Hardin-Hall-Rosbash 1990 to the 2017 Nobel. Identify each major discovery and its significance.
3. Describe the secondary Rev-erbα/Rorα feedback loop and articulate why interlocking loops support clock robustness.
4. Walk the ipRGC-to-SCN photic input pathway and identify how light-induced Per gene induction produces phase shifts.
5. Describe the SCN-peripheral clock hierarchy. What happens to peripheral clocks under chronic late eating despite normal light-driven SCN entrainment?
6. Articulate the lateral relationship to Sleep Bachelor's Lesson 2. How do photic-entrainment and sleep-regulation angles complement each other on the same TTFL machinery?

---

Lesson 3: Phase Response Curves and Clinical Chronotherapy

Learning Objectives

By the end of this lesson, you will be able to:

• Describe the human phase response curve (PRC) to light at intervention-trial depth (Khalsa et al. 2003 Journal of Physiology)
• Identify the time-of-day and intensity specifications of phase-advancing vs phase-delaying light exposures
• Describe Chang et al. 2015 PNAS evening blue light and melatonin suppression at full methodology
• Distinguish controlled-laboratory blue-light effects from wellness-industry blue-light-glasses overclaim
• Engage with the IARC 2007 shift-work as Group 2A probable carcinogen classification at full methodology, including the 2019 reaffirmation
• Apply chronotherapy frameworks to jet lag and other circadian disruption contexts

Key Terms

The Human PRC to Light: Khalsa 2003 at Intervention-Trial Depth

The human phase response curve to light has been characterized in substantial detail through controlled laboratory studies. The foundational modern paper is Sarah Khalsa, Megan Jewett, Christian Cajochen, and Charles Czeisler's 2003 Journal of Physiology paper A phase response curve to single bright light pulses in human subjects [25]. The paper provided detailed dose-response and timing data for the human PRC under controlled forced-desynchrony conditions.

The findings:

• Phase delay zone — Bright light exposure during the late evening through early morning (before core body temperature minimum, which typically occurs ~2-3 hours before habitual wake time) produces phase delay. The human circadian rhythm shifts to a later time the following day.
• Phase advance zone — Bright light exposure during the late morning hours after core temperature minimum (early subjective morning) produces phase advance. The rhythm shifts to an earlier time the following day.
• Dead zone — Bright light exposure during the late afternoon and early evening produces minimal phase shift; the system is largely insensitive to light during this window.
• Dose-response — Phase shift magnitude scales with light intensity (lux) and duration. The Khalsa 2003 paper specifically examined ~10,000 lux exposures; phase shifts approaching 3 hours have been documented under maximal exposure conditions.

The PRC has clinical and practical implications:

• Morning light advances the circadian rhythm — Useful for individuals who want to wake earlier (delayed sleep phase, late chronotype, eastward jet lag adjustment). Bright outdoor light in the early morning hours after habitual wake produces phase advance.
• Evening light delays the circadian rhythm — Useful for individuals who want to stay up later (advanced sleep phase, westward jet lag). Evening bright light produces phase delay.
• Late-night light is delay-producing and consequential — Light exposure during the typical evening-into-bedtime hours (when ipRGC sensitivity is high and the system is in the delay zone) can chronically push the circadian phase later. This is one of the substrates of the modern indoor-evening-light environment as chronobiological mismatch.

For pre-clinical students moving toward sleep medicine, the PRC framework is core knowledge. Clinical applications include:

• Delayed sleep phase syndrome — Treated with combination of timed morning bright light therapy and evening light avoidance, sometimes with timed melatonin.
• Advanced sleep phase syndrome — Treated with timed evening bright light therapy.
• Shift work — Timed light interventions can support partial adaptation to imposed night-shift schedules.
• Jet lag — Timed light exposure based on the direction and magnitude of travel can accelerate phase adjustment.

The chapter teaches the framework; specific protocols belong in clinical conversations with sleep medicine specialists.

Evening Blue Light: Chang 2015 at Full Methodology

In 2015, Anne-Marie Chang, Daniel Aeschbach, Jeanne Duffy, and Charles Czeisler published in PNAS the paper Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness [26]. The study has been widely cited in wellness-industry framing of evening screen exposure; the Bachelor's-level reading discipline requires understanding the methodology and findings.

The methodology:

• Design — Crossover study in 12 healthy adults. Each participant spent 4 hours reading either a light-emitting eReader (iPad set to maximum brightness) or a printed book in dim light, for 5 evenings of each condition.
• Outcome measures — Salivary melatonin levels (timing of melatonin onset), polysomnography (sleep onset latency, REM sleep duration), subjective alertness, and morning melatonin offset.
• Comparison — Within-subject crossover, eliminating between-subject confounders.

The findings:

• Melatonin onset delayed by ~1.5 hours on eReader nights compared to print nights.
• Sleep onset latency increased by ~10 minutes on eReader nights.
• REM sleep duration reduced on eReader nights.
• Morning alertness reduced on eReader nights despite same total sleep time.
• Subjective sleepiness ratings increased in the eReader morning condition.

What the study demonstrated:

• Substantial evening light exposure from a tablet device at maximum brightness produces measurable melatonin suppression and circadian phase delay.
• The effect was robust under controlled conditions with within-subject comparison.

What the study did NOT demonstrate:

• The study did NOT show that typical real-world phone or tablet use at lower brightness produces equivalent effects.
• The study did NOT show that blue-light-blocking glasses, blue-light filters, or screen color shifting consumer products effectively prevent the observed effects.
• The study did NOT examine effects in children, adolescents, or clinical populations.
• The study did NOT establish long-term consequences of chronic evening screen exposure.

The popular framing of "blue light from screens is destroying your sleep" exceeds what Chang 2015 (and similar laboratory studies) actually demonstrated. The framework is approximately:

• Yes — Evening short-wavelength light at sufficient intensity produces measurable circadian effects.
• Yes — Reduction of evening light intensity (dimmer screens, less screen time, less bright indoor lighting) likely supports better sleep timing in many adults.
• Yes but — The specific magnitude of effect at typical real-world consumer screen use is not the same as in laboratory maximum-brightness conditions.
• Unclear — Consumer blue-light-blocking products (glasses, screen filters) have weaker evidence base than the underlying biology might suggest. Some studies of these products show effects; others do not. Effect sizes are often modest [27][28].

For pre-clinical students: the underlying biology (ipRGC photoreception, melatonin suppression, circadian phase shifting) is real and well-grounded. The wellness-industry expansion to "blue light is destroying everything" exceeds the research. The consumer-product framework (blue-light glasses, filters) has more uneven evidence than the marketing suggests.

Shift Work and IARC Cancer Classification

The shift work / circadian disruption / cancer relationship is one of the more substantial public health surfaces in circadian biology. The principal framework comes from the International Agency for Research on Cancer (IARC).

In 2007, an IARC working group classified shift work that involves circadian disruption as Group 2A: probably carcinogenic to humans [29]. The classification was based on:

• Strong mechanistic evidence in animal models — Circadian disruption (in light-cycle shift experiments and other paradigms) accelerates tumor growth in multiple rodent cancer models.
• Limited epidemiological evidence in humans — Several large cohort studies (notably the Nurses' Health Study) showed modest elevations in breast cancer incidence among long-term night-shift workers, with some studies showing dose-response relationships with years of shift work.
• Plausible biological mechanism — Melatonin suppression (from light-at-night exposure) was hypothesized as a key mediator, with melatonin's documented anti-proliferative effects in vitro and in some animal models supporting the framework.

The classification was reaffirmed in 2019 after additional epidemiological evidence had accumulated. The 2019 working group reviewed the additional cohort studies and found the body of evidence consistent with the 2007 classification, though several studies in the intervening period had produced inconsistent findings, and the working group acknowledged that the strength of human evidence remains limited (rather than sufficient, which would lead to Group 1 classification — "definitely carcinogenic") [30].

The methodological reading discipline:

• Group 2A means "probably carcinogenic" with limited human evidence and sufficient animal/mechanistic evidence. The classification is meaningful and reflects substantial concern; it is not equivalent to Group 1 (definite human carcinogen).
• Observational human evidence has substantial limitations. Shift workers differ from day workers in many factors beyond shift work itself (socioeconomic factors, lifestyle behaviors, exposure to other environmental factors); residual confounding is plausible.
• The mechanism is hypothesized but not causally proven. Light-at-night → melatonin suppression → permissive for tumor growth is biologically plausible, but the chain has not been definitively demonstrated in human cancer.
• Subsequent epidemiological studies have been mixed. Some have confirmed the breast cancer signal, others have not; meta-analyses produce intermediate effect estimates.

For pre-clinical students and policymakers: shift work appears to elevate cancer risk modestly, with breast cancer the principal documented signal. The mechanism likely involves circadian disruption and possibly melatonin suppression but is not definitively established. Public health implications include reasonable concern about long-term shift work patterns, support for research into mitigation strategies, and recognition that the evidence base remains methodologically constrained.

Jet Lag Chronotherapy

Jet lag represents acute circadian misalignment from rapid time-zone transitions. The SCN entrains to local light cues at approximately 1 time zone per day in the phase-advance direction (eastward travel) and ~1.5 time zones per day in the phase-delay direction (westward travel) [31].

Chronotherapy for jet lag uses the PRC framework. Strategic light exposure:

• Eastward travel (need to phase advance) — Bright morning light at the destination accelerates phase advance. Avoid evening light at destination that would produce phase delay.
• Westward travel (need to phase delay) — Bright evening light at the destination accelerates phase delay. Avoid morning light that would produce phase advance.

Strategic melatonin (in adults under appropriate clinical guidance):

• Eastward travel — Evening melatonin at the destination supports phase advance.
• Westward travel — Morning melatonin (in some protocols) supports phase delay; effect is less consistent than the eastward direction.

Behavioral chronotherapy — adjusting meal times, exercise timing, social schedules to the destination time zone — supports overall adaptation alongside the photic and pharmacological interventions.

The contemporary "athletic jet lag" research, particularly in international competition contexts, has refined these frameworks for specific populations [32]. The frameworks belong in clinical and athletic medicine conversations rather than personal prescription; the chapter teaches the science.

Lesson Check

1. Describe the human PRC to light. Identify the phase advance zone, phase delay zone, and the dead zone, and articulate the relationship to core body temperature minimum.
2. Identify the Khalsa et al. 2003 Journal of Physiology foundational PRC paper. What dose-response data did it establish?
3. Walk the Chang et al. 2015 PNAS methodology and findings. What did the study demonstrate about evening eReader use, and what specifically did it not demonstrate?
4. Articulate the limits of consumer blue-light-blocking product claims relative to controlled laboratory research on evening blue light.
5. Engage with the IARC 2007/2019 classification of shift work as Group 2A. What is the strength of the evidence, what are the methodological limits, and what does the classification mean clinically and for public health?
6. Apply chronotherapy frameworks to a jet lag scenario of your choosing. Identify the directional considerations (eastward vs westward) and the principal interventions.

---

Lesson 4: Vitamin D Biochemistry and Bone Health

Learning Objectives

By the end of this lesson, you will be able to:

• Walk the vitamin D synthesis cascade from cutaneous 7-dehydrocholesterol through hepatic 25-hydroxylation and renal 1α-hydroxylation
• Describe the vitamin D receptor (VDR) as a nuclear hormone receptor and walk the VDR-RXR heterodimer transcriptional regulation of calcium and phosphate homeostasis
• Articulate the latitude, season, skin pigmentation, and age variables affecting cutaneous vitamin D synthesis
• Engage with the IOM 2011 sufficiency threshold (20 ng/mL 25(OH)D) versus the Endocrine Society guideline (30 ng/mL) debate at intervention-trial depth
• Describe the VITAL trial (Manson et al. 2019 NEJM) and articulate the null findings for cardiovascular and cancer endpoints
• Apply descriptive-not-prescriptive framing to vitamin D supplementation throughout

Key Terms

Vitamin D Synthesis: Cutaneous Through Renal at Molecular Depth

Vitamin D is properly classified as a hormone rather than a vitamin — it is synthesized in the body from a cholesterol precursor, activated through two hydroxylations, and acts through a nuclear receptor. The "vitamin" name reflects historical accident and dietary availability. At Bachelor's depth the hormone framing is the more accurate one [33][34].

The synthesis pathway:

1. 7-Dehydrocholesterol (7-DHC) — A cholesterol biosynthesis intermediate accumulates in the basal and spinous layers of skin epidermis.
2. UVB photoisomerization — Solar UVB radiation (280-315 nm) photoisomerizes 7-DHC to pre-vitamin D₃.
3. Thermal isomerization — Pre-vitamin D₃ thermally isomerizes to cholecalciferol (vitamin D₃) over hours at skin temperature. The thermal step is temperature-dependent.
4. DBP transport — Vitamin D binding protein (DBP) carries cholecalciferol in plasma to the liver.
5. Hepatic 25-hydroxylation — CYP2R1 (principally) and to a lesser extent CYP27A1 hydroxylates D₃ at C-25 to produce 25-hydroxyvitamin D (25(OH)D, calcidiol). This metabolite has a long half-life (~2-3 weeks) and is the standard clinical marker of vitamin D status. Most adult 25(OH)D measurements reflect cumulative production and intake over weeks.
6. Renal 1α-hydroxylation — CYP27B1 in the kidney hydroxylates 25(OH)D at the 1α position to produce 1,25-dihydroxyvitamin D (1,25(OH)₂D, calcitriol) — the hormonally active form. Some peripheral tissues (immune cells, certain epithelia) also express CYP27B1 and produce local 1,25(OH)₂D for autocrine/paracrine action.

The VDR as Nuclear Hormone Receptor

The vitamin D receptor (VDR) is a member of the nuclear hormone receptor superfamily, structurally related to thyroid hormone, retinoid, steroid hormone, and other nuclear receptors. The mechanism [35][36]:

1. 1,25(OH)₂D binds VDR in the cytoplasm or nucleus.
2. VDR-RXR heterodimerization — Ligand-bound VDR heterodimerizes with the retinoid X receptor (RXR).
3. VDRE binding — The VDR-RXR heterodimer binds vitamin D response elements (VDREs) — specific DNA sequences in target gene promoters — typically consensus PuG(G/T)TCA direct repeats with 3-nucleotide spacing (DR3).
4. Coregulator recruitment — Coactivators (e.g., SRC family, mediator complex) are recruited; histone modifications and chromatin remodeling occur; transcription of target genes proceeds.
5. Repression at other sites — At some target sites, VDR-RXR represses transcription through corepressor recruitment.

The VDR is expressed in many tissues beyond the classical bone-and-kidney targets — immune cells (T cells, B cells, dendritic cells, macrophages), epithelia (intestinal, prostatic, mammary, others), skeletal muscle, pancreas, brain. The breadth of VDR expression supports the framework that vitamin D has multiple physiological roles beyond calcium and phosphate homeostasis.

The Classical Vitamin D Axis: Calcium and Phosphate Homeostasis

The principal classical actions of 1,25(OH)₂D involve calcium and phosphate handling [37][38]:

• Intestinal absorption — 1,25(OH)₂D upregulates calcium absorption from the small intestine through induced expression of calcium transporters (TRPV6, calbindin-D9k) and other components.
• Renal reabsorption — 1,25(OH)₂D supports calcium reabsorption in renal distal tubules.
• Bone — 1,25(OH)₂D supports both osteoblast differentiation and (at higher doses) osteoclast activation. The integrated effect on bone is complex; physiological 1,25(OH)₂D supports normal bone mineralization, while pathological excess (or deficiency) produces bone disease.
• Parathyroid feedback — 1,25(OH)₂D suppresses parathyroid hormone (PTH) expression in parathyroid cells. The PTH-vitamin D-calcium axis is a tightly regulated negative feedback system.

The integrated axis: low serum calcium → PTH ↑ → renal CYP27B1 ↑ → 1,25(OH)₂D ↑ → intestinal calcium absorption ↑, bone resorption ↑, renal calcium reabsorption ↑ → serum calcium restored. High serum calcium → PTH ↓ → 1,25(OH)₂D ↓ → opposite effects → serum calcium reduced.

The vitamin D deficiency clinical phenotype:

• Rickets in children — Bone mineralization failure during growth; characteristic bone deformities; preventable and treatable with vitamin D supplementation.
• Osteomalacia in adults — Bone matrix produced but inadequately mineralized; muscle weakness, bone pain, fracture risk.
• Severe deficiency (typically 25(OH)D <12 ng/mL in research definitions) produces these established clinical phenotypes.

Beyond these classical bone-disease consequences, vitamin D status has been investigated for relationships with cardiovascular disease, certain cancers, immune function, muscle function, mood, and other outcomes. The state of evidence varies substantially across these proposed extraskeletal effects, and the chapter returns to this below.

Latitude, Season, Skin Pigmentation, Age Variables

Cutaneous vitamin D synthesis depends on multiple variables that affect UVB exposure to the skin [39][40]:

Latitude — At latitudes above approximately 35° (most of the United States above southern California and most of Europe), UVB intensity from October through March is insufficient to support meaningful vitamin D synthesis at most times of day. At high latitudes (>40°), the winter "vitamin D winter" can extend from late September through early April. Equatorial populations have year-round UVB availability for vitamin D synthesis.

Season — Solar zenith angle determines UVB intensity at the surface. Higher zenith angle (winter, morning, evening) produces more atmospheric absorption and reduced UVB. Maximum vitamin D synthesis occurs in midday hours during summer.

Skin pigmentation — Melanin in skin absorbs UV radiation; more melanin reduces UVB available for 7-DHC photoisomerization. Individuals with darker skin pigmentation produce less vitamin D per unit UVB exposure than individuals with lighter skin pigmentation. The descriptive physiology: dark-skinned individuals at high latitudes have substantially lower mean 25(OH)D levels than light-skinned individuals at the same latitudes, all else equal. The framing throughout is descriptive — this is biology, not a value judgment; the evolutionary context (melanin evolution shaped by ancestral UV environment) is part of the picture but does not change the contemporary clinical implications.

Age — Aging skin produces less 7-DHC and is less efficient at the photoisomerization step. Elderly individuals typically have lower vitamin D synthesis capacity than younger adults at equivalent UVB exposure.

Other factors — Body coverage by clothing, sunscreen use (substantial UVB blocking at SPF 15+), indoor lifestyle, and obesity (sequesters vitamin D in adipose tissue) further modify the UVB-to-circulating-vitamin-D relationship.

The integrated picture: many adults in industrialized populations at moderate to high latitudes have suboptimal vitamin D status (as defined by the principal sufficiency thresholds), with higher prevalence in dark-skinned populations, elderly populations, individuals with limited outdoor exposure, and individuals with obesity. The clinical implications are real but complicated by the supplementation evidence below.

The IOM 2011 vs Endocrine Society Sufficiency Debate

A substantial controversy exists in vitamin D research regarding what serum 25(OH)D level constitutes sufficiency. The two principal positions [41][42]:

Institute of Medicine 2011 Report — The IOM (now National Academy of Medicine) committee on dietary reference intakes for vitamin D and calcium recommended:

• Severe deficiency (likely producing rickets/osteomalacia in many): 25(OH)D < 12 ng/mL (< 30 nmol/L).
• Risk of inadequacy: 25(OH)D 12-20 ng/mL (30-50 nmol/L).
• Sufficiency for bone health in most of the general population: 25(OH)D > 20 ng/mL (> 50 nmol/L).
• Recommended dietary allowance: 600 IU daily for most adults, 800 IU for adults over 70.

Endocrine Society 2011 Guidelines — Released the same year, focusing on patient evaluation and treatment:

• Deficiency: 25(OH)D < 20 ng/mL.
• Insufficiency: 25(OH)D 21-29 ng/mL.
• Sufficiency: 25(OH)D ≥ 30 ng/mL.
• Recommended supplementation: 1500-2000 IU daily for most adults; higher amounts for those at risk.

The two frameworks differ substantially:

• The IOM threshold (20 ng/mL) is approximately 2/3 of the Endocrine Society threshold (30 ng/mL).
• The IOM framework targets general population bone health; the Endocrine Society framework targets patients being evaluated for and treated for vitamin D-related conditions.
• The IOM committee considered the supplementation evidence more skeptically than the Endocrine Society guidelines; the Endocrine Society guidelines were more permissive of supplementation based on observational associations between low 25(OH)D and various conditions.

The 2024 Endocrine Society update somewhat tempered the earlier recommendations, acknowledging that vitamin D supplementation in general populations without specific risk factors has limited evidence base for benefit beyond bone health [43].

The debate reflects a broader pattern: observational research showed associations between low 25(OH)D and various health outcomes, generating substantial enthusiasm for vitamin D supplementation as preventive medicine; randomized trial research has subsequently produced mixed and often null results for these supplementation strategies.

The VITAL Trial: Manson et al. 2019 at Intervention-Trial Depth

The Vitamin D and Omega-3 Trial (VITAL), led by JoAnn Manson at Brigham and Women's Hospital, examined vitamin D₃ supplementation (2000 IU/day) and marine omega-3 (1g/day) versus placebos for prevention of cardiovascular events and cancer in a general-population sample of 25,871 U.S. adults followed for a median of 5.3 years [44].

The methodology:

• Design — 2x2 factorial randomization to vitamin D₃ + omega-3 (or placebo) and omega-3 + vitamin D (or placebo). Effectively four groups: both supplements, vitamin D only, omega-3 only, neither.
• Population — General population adults (men ≥50, women ≥55), not selected for vitamin D deficiency, with broadly representative US demographics.
• Outcomes — Primary: invasive cancer and major cardiovascular events. Secondary: cancer mortality, cardiovascular mortality, several specific cancer types, others.

The findings:

• Vitamin D₃ supplementation did NOT reduce invasive cancer incidence (HR 0.96, 95% CI 0.88-1.06).
• Vitamin D₃ supplementation did NOT reduce major cardiovascular events (HR 0.97, 95% CI 0.85-1.12).
• No effect on overall cancer mortality in the principal analysis.
• No effect on cardiovascular mortality in the principal analysis.
• Some subgroup signals in pre-specified secondary analyses (cancer mortality reduction in black participants, some hints of effects in specific subgroups) but not large enough or robust enough across subgroups to support general clinical conclusions.

What the trial demonstrated:

• In a general-population sample of older U.S. adults not selected for vitamin D deficiency, 2000 IU/day vitamin D₃ supplementation for over 5 years did NOT reduce overall cancer or cardiovascular disease incidence.

What the trial did NOT demonstrate:

• The trial did NOT examine populations with substantial vitamin D deficiency at baseline; participants enrolled with broadly representative 25(OH)D distributions, not the lowest tiers.
• The trial did NOT examine other outcomes that have been proposed as vitamin D-responsive (autoimmune disease, infection susceptibility, certain other conditions).
• The trial did NOT examine higher supplementation doses than 2000 IU/day.

The 2022 VITAL follow-up papers and subsequent analyses have extended the original findings to additional endpoints; several have shown modest effects in specific subgroups (e.g., autoimmune disease reduction in some analyses), but the principal cardiovascular and cancer endpoints remain null.

The Bachelor's-level reading discipline:

• The observational research showing associations between low 25(OH)D and cardiovascular disease, cancer, and other outcomes did NOT translate into demonstrable benefit from supplementation in the general-population setting tested by VITAL.
• The discrepancy between observational and trial findings is one of the standard cautionary cases in clinical research (parallel to similar discrepancies for vitamin E, beta-carotene, hormone replacement therapy, and other observation-vs-trial divergences).
• The clinical implication is not that vitamin D is unimportant — severe deficiency clearly produces clinical phenotypes; supplementation in deficient populations remains appropriate. The clinical implication is that routine supplementation in general adult populations without identified deficiency is not supported by the major randomized trial evidence for cardiovascular and cancer prevention.

Lesson Check

1. Walk vitamin D synthesis from cutaneous 7-DHC through hepatic CYP2R1 25-hydroxylation to renal CYP27B1 1α-hydroxylation. Identify what clinical-status measurement most clinicians use and why.
2. Describe the VDR as a nuclear hormone receptor and walk the VDR-RXR heterodimer transcriptional regulation through VDRE binding.
3. Articulate the latitude, season, skin pigmentation, and age variables affecting cutaneous vitamin D synthesis. Why do dark-skinned individuals at high latitudes have substantially lower mean 25(OH)D than light-skinned individuals at the same latitudes?
4. Distinguish the IOM 2011 (20 ng/mL) and Endocrine Society (30 ng/mL) sufficiency thresholds. What underlies the disagreement, and what does the 2024 Endocrine Society update reflect?
5. Walk the VITAL trial methodology and findings. What did the trial demonstrate for general-population vitamin D supplementation and cardiovascular/cancer endpoints?
6. Apply the descriptive-not-prescriptive framing. Why does this chapter teach vitamin D biochemistry at depth but route specific supplementation decisions to clinical conversation?

---

Lesson 5: Light Therapy Clinical Research and Modern Light Environment Pathophysiology

Learning Objectives

By the end of this lesson, you will be able to:

• Describe Norman Rosenthal et al. 1984 Archives of General Psychiatry SAD discovery at foundational depth
• Walk the subsequent bright-light therapy RCT literature and identify light box specifications used in intervention research
• Describe Wright et al. camping studies on natural-light SCN entrainment
• Engage with Roenneberg social jet lag epidemiology at population health depth
• Identify the IARC night-shift classification revisited in clinical and public health context
• Apply the five-point evaluation framework to "circadian medicine" claims

Key Terms

The Rosenthal 1984 SAD Discovery

In 1984, Norman Rosenthal, Thomas Sack, J. Christian Gillin, Alfred Lewy, Frederick Goodwin, Yolande Davenport, Peter Mueller, David Newsome, and Thomas Wehr published in Archives of General Psychiatry the paper Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy [45]. The paper had two principal contributions:

First, the description of seasonal affective disorder (SAD) — A mood disorder with seasonal pattern, typically winter onset, characterized by:

• Depressive symptoms with onset in fall or winter and remission in spring or summer
• Atypical features (carbohydrate craving, weight gain, hypersomnia) more common than typical features (insomnia, weight loss)
• High prevalence at higher latitudes; reduced prevalence at equatorial latitudes
• Family history pattern suggesting heritable component

Second, the demonstration of bright light therapy as treatment — The original 1984 paper reported preliminary findings showing that bright light exposure (initially with full-spectrum lights at 2500 lux for hours daily) reduced depressive symptoms in SAD patients, with effects emerging over days to weeks of treatment.

The SAD discovery and the introduction of bright light therapy launched the contemporary chronotherapeutics field. Subsequent decades of research have substantially refined the understanding:

• Diagnostic criteria — SAD is now incorporated into the DSM as "major depressive disorder with seasonal pattern" and "bipolar disorder with seasonal pattern."
• Light box specifications — Standard research and clinical light therapy uses 10,000 lux for approximately 30 minutes daily, typically in the morning hours.
• Mechanism — Initially hypothesized as principally circadian (correcting phase delays in winter), the mechanism is now understood to involve combined direct effects on alerting/mood regulation through ipRGC pathways to brainstem and limbic targets, in addition to circadian phase shifts. The melanopsin-rich ipRGC photoreception (Lesson 1) is the principal substrate of light therapy's effects.
• Comparable efficacy to antidepressants in SAD — Light therapy has demonstrated similar effect sizes to SSRI antidepressants in SAD specifically, with faster time-to-effect and a different side effect profile [46].
• Less effective in non-seasonal depression — Light therapy has been examined in non-seasonal major depressive disorder with smaller and more variable effect sizes; the clinical application is principally to SAD.

For pre-clinical students, the SAD/light therapy story is one of the cleaner translational arcs in psychiatry: a clinical syndrome identification, a hypothesis about mechanism (light environment as causal), an intervention test, and a sustained evidence base over four decades. The framework belongs in clinical psychiatric and primary care conversations; the chapter teaches the science.

Bright Light Therapy Clinical Specifications

The contemporary research and clinical use of bright light therapy [47][48]:

Intensity — 10,000 lux is the standard. Light at this intensity activates melanopsin (ipRGC) photoreception substantially while remaining safe for typical indoor use. Lower intensities (2,500-5,000 lux) require longer exposure durations and are sometimes used as alternatives.

Wavelength — Broad-spectrum white light is the historical standard. More recent products use blue-enriched spectra that target melanopsin's 480 nm sensitivity peak more efficiently, allowing potentially lower lux requirements; the relative efficacy of broad-spectrum versus blue-enriched at typical clinical exposures remains an active research area.

Duration — 30 minutes daily is the typical clinical protocol. Some patients use longer durations; effect sizes appear to follow dose-response within reasonable ranges.

Timing — Morning (within first 1-2 hours of waking) is the standard for SAD and most chronotherapeutic uses. Evening timing produces phase delay and is generally contraindicated for SAD; it has specific uses in advanced sleep phase syndrome.

Position — Light box positioned 16-24 inches from the eyes; patient does not look directly at the light box but allows ambient light to enter the eyes during normal activity (reading, eating, working at desk). Direct staring is unnecessary and produces eye strain.

Duration of treatment course — In SAD, ongoing during the depressive-pattern season; some patients use it throughout the year, others only during winter.

Side effects — Generally mild and time-limited: headache, eye strain, nausea, agitation in some patients. Mania induction risk in bipolar patients warrants psychiatric monitoring.

Contraindications — Specific retinal conditions, certain photosensitizing medications, untreated bipolar disorder, and other contexts warrant clinical consultation before initiation.

The framework belongs in clinical conversations; the chapter teaches the specifications.

Dawn Simulation Research

A complementary approach to bright light therapy is dawn simulation — gradually increasing artificial light during the late sleep period to mimic natural dawn. The principle: ipRGC photoreception even through closed eyelids during light sleep can produce circadian effects [49][50]:

• Mechanism — Light penetration through closed eyelids is sufficient for some melanopsin activation; gradual brightening during the late sleep period engages the system without requiring conscious wakefulness.
• Clinical research — Several RCTs in SAD have shown dawn simulation efficacy comparable to or somewhat less than bright light therapy; effect sizes are modest.
• Practical applications — Dawn simulation alarm clocks are commercially available; the clinical evidence for non-SAD applications is limited.

Dawn simulation represents one of the more accessible chronotherapeutic interventions; the chapter teaches it descriptively as part of the broader chronotherapy framework.

Wright Camping Studies: Natural-Light SCN Entrainment

Kenneth Wright and colleagues at the University of Colorado Boulder have conducted research demonstrating the rapid effect of natural light environments on the SCN. The principal findings [51][52]:

The 2013 Current Biology paper — Adult volunteers underwent baseline measurement of circadian phase (typically through salivary melatonin onset) during normal modern indoor-light lifestyles. They then spent 7 days summer camping in the Rocky Mountains with no artificial light (no flashlights, no phones, no electric light of any kind), exposed only to natural sunlight and campfires. Circadian phase was re-measured. Findings:

• Average circadian phase advanced by approximately 2 hours after one week of natural-light camping.
• Inter-individual variability in chronotype (the spread of late versus early chronotypes) narrowed substantially during camping.
• The post-camping circadian timing was tightly coupled to dawn — most participants' melatonin onset and offset aligned closely with sunset and sunrise.

The 2017 winter follow-up — A similar paradigm in winter showed:

• Even more pronounced phase advances during winter camping (when natural light is more limited).
• The effect persists after return to modern light environments for some duration.

The Wright camping research demonstrates that the modern indoor light environment substantially deviates from the natural light environment in which human circadian biology evolved. The deviation produces measurable delays in circadian timing and increases in inter-individual chronotype variability. The implications:

• Natural daylight is a far more potent circadian signal than typical indoor electric light. Modern indoor lifestyles produce attenuated and mistimed light input to the SCN.
• Chronotype variation may be partly environmental. The genetic-versus-environmental contribution to chronotype in modern populations is complicated by the modern light environment; in natural light, individuals' "natural" chronotype is more closely aligned across people than indoor lifestyles allow.
• The behavioral implication — Morning outdoor light exposure substantially supports circadian alignment; the wellness-industry framing of "10 minutes of morning sunlight" reflects this biology, though the specific dose-response and protocol details remain an active research area.

The chapter takes the descriptive position: morning outdoor light exposure aligns circadian biology with the day-night cycle. Specific protocols (how many minutes, exact timing) belong in clinical and personal-application conversations.

Roenneberg Social Jet Lag at Population Health Depth

Till Roenneberg's social jet lag framework, introduced in Sleep Bachelor's Lesson 2 and elaborated here, provides a population-health-scale measure of chronic circadian misalignment in modern populations [53][54]:

Definition — Social jet lag is the absolute difference between sleep midpoint on free days and on workdays. An individual whose sleep midpoint shifts 2 hours later on weekends than weekdays has 2 hours of social jet lag — functionally a 2-hour westward time-zone shift twice a week.

Population epidemiology — In large European and U.S. population samples (Munich Chronotype Questionnaire surveys, others), median social jet lag is approximately 1 hour; substantial fractions of populations have 2+ hours; smaller fractions have 3+ hours. Late-chronotype individuals (eveningness) typically have higher social jet lag than early-chronotype individuals (morningness).

Associated outcomes — Cross-sectional and longitudinal studies have associated social jet lag with:

• Cardiometabolic risk factors (BMI, glucose tolerance, lipid profile, blood pressure)
• Mood symptoms (depression, anxiety scores)
• Cognitive performance variation
• Substance use patterns (alcohol, caffeine consumption)
• Academic performance in adolescent and young adult populations

The associations are observational and subject to confounding; causal interpretation is constrained. The framework supports the general claim that chronic chronotype-schedule mismatch is consequential for health, with specific clinical translation an active research area.

Public health implications — School start times (the substantial literature on delayed high school start times improving sleep, academic performance, and adolescent mental health), shift work scheduling, workplace flexibility, and the broader population health framework all reflect engagement with the social jet lag concept.

The Modern Indoor Light Environment as Chronobiological Mismatch

The integrated picture across Wright camping research, Roenneberg social jet lag epidemiology, and the broader circadian biology research [55][56]:

• The modern indoor lifestyle exposes adults to substantially less daytime outdoor light than the lifestyle in which human circadian biology evolved.
• Modern artificial lighting in the evening exposes adults to more evening short-wavelength light than the lifestyle in which human circadian biology evolved.
• The combination — reduced daytime entrainment plus increased evening entrainment of the opposite direction — produces population-scale chronic circadian misalignment.
• The misalignment has measurable consequences for sleep, mood, metabolic health, cognitive performance, and likely additional outcomes.

The framework is well-supported by the cumulative research. The mechanisms are well-characterized at the photic-entrainment-of-SCN level (Lesson 1 and Lesson 2 biology). The clinical translation — what individuals should do — is more variable, with personal lighting environment, work and social schedule, geographic latitude, age, chronotype, and many other factors interacting.

For pre-clinical students moving toward sleep medicine, psychiatry, primary care, public health, occupational medicine, or other relevant fields, the framework is contemporary core knowledge. The interventions (morning outdoor light, evening light minimization, consistent sleep schedule, age-appropriate school start times) are reasonable and well-grounded; the specific implementation belongs in clinical and personal-application conversations.

The Five-Point Evaluation Framework Applied to Circadian Medicine Claims

The framework introduced in Breath Associates and operating across all Bachelor's chapters extends to chronobiology and "circadian medicine" claims specifically:

1. Mechanism plausibility — Phase-shifting effects of light through ipRGC-SCN pathways are well-grounded; claims about specific intervention effects on cognitive performance or longevity that exceed phase-shifting mechanisms typically exceed what is well-grounded.

2. Study design — Khalsa-style controlled PRC studies are well-designed; population-scale observational research on social jet lag is hypothesis-generating but observational; consumer-product trials (blue-light glasses, light therapy products) vary widely in methodological quality.

3. Effect size in context — Light therapy in SAD has clinically meaningful effect sizes; morning outdoor light exposure for general well-being has more modest documented effects; specific consumer-product effects are often smaller than marketing implies.

4. Replication across populations — Findings in young healthy adults do not automatically translate to older adults, clinical populations, or specific chronotype subpopulations.

5. Translation appropriateness — Research findings on circadian effects don't directly support consumer-product prescription; clinical decisions about light therapy, melatonin, or other chronotherapy belong in clinical conversations.

Most popular "circadian medicine" claims fail at points 3 (effect-size inflation), 4 (population over-generalization), or 5 (over-translation from research to personal prescription).

The Rooster's Integrator Position at Bachelor's: Synchronizer, Deepened

A closing structural point. At Associates depth, the Rooster's integrator position was named as synchronizer — the entrainment signal that aligns the body's internal rhythms to the 24-hour environmental cycle. The only position grounded in external information rather than internal regulatory function.

At Bachelor's depth, the synchronizer position deepens at molecular and gene-expression level. Light is not abstractly "timing information"; it is specific molecular events:

• Photoreception — ipRGCs (Lesson 1) translate photons of specific wavelengths through melanopsin into neural signals.
• SCN entrainment — Glutamate and PACAP release at SCN drive Per1/Per2 induction in pacemaker neurons.
• Phase shifting — The phase response curve (Lesson 3) at molecular resolution: light at the wrong phase produces phase shifts because Per induction at different times affects the existing TTFL oscillation differently.
• Endocrine timing — Melatonin production by the pineal gland is suppressed by SCN-mediated light input; the daily melatonin profile is a downstream readout of the integrated photic-entrainment system.
• Vitamin D biology — A related but distinct photobiological axis (Lesson 4): UVB drives cutaneous synthesis through 7-DHC photoisomerization. The vitamin D axis is photochemistry rather than photoreception, but it is part of the broader skin-as-photobiological-organ framework.

The synchronizer position is structurally distinct from all nine other integrator positions:

• Distinct from substrate (Food) — Substrate is material input; synchronizer is informational timing input.
• Distinct from internal environment (Water) — Internal environment is regulated state; synchronizer is external entrainment cue.
• Distinct from consolidation (Sleep) — Consolidation is temporal pass for adaptation; synchronizer is timing input organizing when the pass happens.
• Distinct from receiver (Brain) — Brain integrates inputs; synchronizer is one specific input (light timing).
• Distinct from active output (Move) — Move is kinetic output; synchronizer is sensory input.
• Distinct from interface (Breath) — Interface is voluntary-autonomic threshold; synchronizer is involuntary entrainment.
• Distinct from system probe (Cold) — System probe is acute reveal; synchronizer is chronic timing.
• Distinct from adaptive load (Hot) — Adaptive load is chronic stress build; synchronizer is chronic timing organization.

The synchronizer position is unique among the ten in being grounded in external information rather than internal regulatory function. The ten-position ontology holds. The final Bachelor's chapter (Water) will test whether the ontology suffices at upper-division depth.

Lesson Check

1. Describe Rosenthal et al. 1984 SAD discovery and the principal features of seasonal affective disorder. Why does light therapy work in SAD specifically?
2. Identify the standard clinical specifications of bright light therapy (intensity, wavelength, duration, timing, position). What contraindications warrant clinical consultation?
3. Describe the Wright et al. camping studies. What do they demonstrate about the modern indoor light environment versus natural light?
4. Engage with Roenneberg social jet lag at population health depth. Identify principal cross-sectional associations and articulate the methodological limits.
5. Articulate the modern indoor light environment as chronobiological mismatch. What are the population health implications and what interventions follow?
6. Apply the five-point evaluation framework to a "circadian medicine" claim of your choosing. Where does it succeed and where does it fail?

---

End-of-Chapter Activity

Activity: Read a Primary Chronobiology Research Paper and Evaluate It Against the Methodological Frame

This activity applies the methodological consciousness Lesson 5 named to a concrete chronobiology research artifact, mirroring the activities at the end of the seven prior Bachelor's chapters.

Step 1 — Select a paper. Pick a primary chronobiology, photobiology, or light-therapy research paper published in the last five years in a major physiology, neuroscience, clinical psychiatry, or sleep medicine journal (Sleep, Journal of Biological Rhythms, Chronobiology International, PNAS, Nature Reviews Neuroscience, Cell Reports Medicine, JAMA Psychiatry, or similar). Note title, authors, journal, year.

Step 2 — Identify the design and population. Specify the design (laboratory PRC study, observational cohort, RCT for clinical intervention, mechanism study at cellular level), the population, the intervention, and the principal outcome measures.

Step 3 — Specify the methodological strengths and limits. Where is this design strong? Where are the chronic problems of chronobiology research most likely to operate (laboratory-to-real-world translation, observational confounding for population research, expectation effects for light therapy)?

Step 4 — Read the effect size in context. What is the magnitude of the reported effect? How does it compare to the inter-individual variation and typical effect-size range?

Step 5 — Evaluate the discussion section critically. Does the discussion acknowledge methodological limits appropriately? Are practical implications stated with appropriate caveats?

Step 6 — Apply the five-point framework. Walk the paper through mechanism plausibility, design adequacy, effect size in context, replication status, and appropriate translation. Write a one-paragraph synthesis.

Deliverable. A 1500-2500 word written analysis with citations to the paper and at least three additional context sources. Include a one-paragraph reflection on what the exercise has taught you about reading chronobiology research.

---

Vocabulary Review

---

Chapter Quiz

Bachelor's-level quiz. Combination of short-answer mechanistic questions, scenario-based application, and methodological critique.

1. Describe rhodopsin phototransduction from photon absorption through membrane hyperpolarization. Identify the role of transducin, PDE, and cGMP.

2. Distinguish the three cone opsin types by wavelength sensitivity and chromosomal location.

3. Identify David Berson's 2002 PNAS paper. What did the discovery establish about retinal photoreception?

4. Describe the M1-M5 ipRGC subtypes by projection target and functional role.

5. Walk the bistable melanopsin photopigment and articulate why it differs from rod/cone opsins.

6. Walk the BMAL1/CLOCK/PER/CRY TTFL at gene regulation depth. Identify E-box sites, the negative feedback arm, and the kinetic features producing ~24-hour period.

7. Trace the historical lineage from Konopka-Benzer 1971 through Hardin-Hall-Rosbash 1990 to the 2017 Nobel.

8. Describe the secondary Rev-erbα/Rorα feedback loop and its contribution to clock robustness.

9. Describe the human PRC to light. Identify the Khalsa 2003 foundational paper and its dose-response and timing data.

10. Walk the Chang 2015 PNAS methodology and findings. What did the study demonstrate, and what does popular framing exceed?

11. Engage with the IARC 2007/2019 classification of shift work as Group 2A. What is the evidence strength, the methodological limits, and the public health implication?

12. Walk vitamin D synthesis from cutaneous 7-DHC through hepatic CYP2R1 to renal CYP27B1. Identify what clinical-status measurement is principally used.

13. Describe the VDR-RXR heterodimer transcriptional regulation. Identify VDRE binding and VDR target gene categories.

14. Articulate the latitude, season, skin pigmentation, and age variables in cutaneous vitamin D synthesis.

15. Distinguish the IOM 2011 (20 ng/mL) and Endocrine Society (30 ng/mL) sufficiency thresholds and identify what underlies the disagreement.

16. Walk the VITAL trial methodology and findings. What did the trial demonstrate for general-population vitamin D supplementation and cardiovascular/cancer endpoints?

17. Describe Rosenthal et al. 1984 SAD discovery and the principal features of SAD. Why does bright light therapy work specifically for SAD?

18. Identify the standard clinical specifications of bright light therapy (intensity, wavelength, duration, timing, position).

19. Describe the Wright et al. camping studies. What do they demonstrate about modern indoor versus natural light environments?

20. Articulate the Rooster's integrator position — synchronizer — at Bachelor's depth. Distinguish it from each of the nine other integrator positions.

---

Instructor's Guide

Pacing Recommendations

This chapter is designed for 18-22 class periods of approximately 50 minutes each — a full-semester upper-division undergraduate course in photobiology, chronobiology, sleep medicine, or environmental physiology. The chapter pairs naturally with Sleep Bachelor's for chronobiology depth and with Brain Bachelor's for SAD and mood neuroscience.

Suggested distribution:

• Lesson 1 — Photobiology at Molecular Receptor Depth: 4-5 class periods.
• Lesson 2 — Molecular Clock Machinery at Gene Expression Resolution: 3-4 class periods.
• Lesson 3 — Phase Response Curves and Clinical Chronotherapy: 3-4 class periods.
• Lesson 4 — Vitamin D Biochemistry and Bone Health: 3-4 class periods.
• Lesson 5 — Light Therapy and Modern Light Environment: 3 class periods.
• End-of-chapter activity: Out-of-class work.
• Quiz / assessment: One to two class periods.

Sample Answers to Selected Quiz Items

Q3 — Berson 2002. David Berson, Felice Dunn, and Motoharu Takao's 2002 PNAS paper Phototransduction by retinal ganglion cells that set the circadian clock established that a subset of retinal ganglion cells respond to light directly, even with rod and cone synaptic input blocked. The photoreceptor pigment is melanopsin (OPN4). These intrinsically photosensitive retinal ganglion cells (ipRGCs) project to SCN and other non-image-forming targets, providing the molecular substrate for mammalian circadian entrainment by light. The discovery answered the decades-old question of what photoreceptor entrains circadian rhythms in mice without functional rods/cones — and revealed that the mammalian retina has two photoreceptive systems (image-forming via rods/cones and non-image-forming via ipRGCs). Parallel to TRPM8 (Cold) and TRPV1 (Hot) as receptor-discovery foundational moments in sensory neuroscience.

Q11 — IARC 2007/2019. In 2007 IARC classified shift work involving circadian disruption as Group 2A (probably carcinogenic to humans). Basis: strong mechanistic evidence in animal models (circadian disruption accelerates tumor growth), limited epidemiological evidence in humans (notably Nurses' Health Study breast cancer signal), plausible mechanism (melatonin suppression from light-at-night with melatonin's documented anti-proliferative effects). The 2019 reaffirmation reviewed additional epidemiological evidence and confirmed Group 2A; the evidence base remains "limited" rather than "sufficient" (which would warrant Group 1 — definite human carcinogen). Methodological limits: shift workers differ from day workers in many factors beyond shift work; residual confounding plausible; subsequent studies have produced mixed results; the mechanism is hypothesized but not causally proven. Clinical and public health implications: shift work appears to modestly elevate cancer risk (principally breast cancer documented); mitigation strategies are reasonable; the evidence base remains methodologically constrained.

Q16 — VITAL trial. Manson et al. 2019 NEJM RCT of 25,871 general-population adults (men ≥50, women ≥55), randomized 2x2 factorial to vitamin D₃ 2000 IU/day or placebo and marine omega-3 1g/day or placebo, followed median 5.3 years. Primary outcomes: invasive cancer and major cardiovascular events. Findings: vitamin D supplementation did NOT reduce invasive cancer (HR 0.96), did NOT reduce major cardiovascular events (HR 0.97). Subgroup signals existed in some pre-specified analyses but not robust across subgroups. Demonstrated: in general-population adults not selected for vitamin D deficiency, 2000 IU/day vitamin D for 5+ years does not reduce overall cancer or cardiovascular disease. Not demonstrated: effects in deficient populations, other proposed vitamin D-responsive outcomes (autoimmune disease, infections), higher supplementation doses. The discrepancy between observational research (showing low 25(OH)D associated with various outcomes) and trial findings (null for principal endpoints) is one of the standard cautionary cases in clinical research, parallel to vitamin E, beta-carotene, and HRT divergences. Implication: severe deficiency clearly requires supplementation; routine supplementation in general populations without identified deficiency is not supported for cardiovascular and cancer prevention.

Q20 — Synchronizer at Bachelor's. Light is the external entrainment signal aligning the body's internal rhythms to the 24-hour environmental cycle. The only position grounded in external information rather than internal regulatory function. At Bachelor's depth: specific molecular events — ipRGC melanopsin photoreception translates photons of ~480 nm peak wavelength into neural signals; SCN entrainment through glutamate and PACAP at retinohypothalamic synapse drives Per1/Per2 induction in pacemaker neurons; phase response curve at molecular resolution; melatonin profile as downstream readout; vitamin D photobiology as related photochemistry axis. Distinct from substrate (Food: material input vs informational timing). Internal environment (Water: regulated state vs entrainment cue). Consolidation (Sleep: temporal pass vs timing organization of when pass happens). Receiver (Brain: input integration vs specific input). Active output (Move: kinetic vs sensory). Interface (Breath: voluntary-autonomic vs involuntary entrainment). System probe (Cold: acute reveal vs chronic timing). Adaptive load (Hot: chronic stress vs chronic timing organization). Synchronizer is unique among the ten in being grounded in external information rather than internal regulatory function.

Discussion Prompts

1. The Berson 2002 ipRGC discovery completed a paradigm shift in mammalian sensory neuroscience that includes the TRPM8 and TRPV1 receptor-discovery papers. What does the convergence of these three molecular foundational moments in a five-year window teach about how sensory neuroscience advances?

2. The molecular clock lineage from Konopka-Benzer 1971 to the 2017 Nobel spans 46 years of research. What does this trajectory teach about the timescale of fundamental biology and the patience required for paradigm-shifting research?

3. The VITAL trial's null findings for general-population vitamin D supplementation contrast with the substantial observational evidence base. How should pre-clinical students hold the discrepancy between observational and randomized trial findings — a recurring pattern in nutrition and supplement research?

4. The IARC shift work classification is consequential public health policy. How should pre-clinical students balance the methodological limits of the evidence base against the substantial population health implications?

5. The Wright camping studies demonstrate rapid SCN entrainment to natural light cycles. The modern indoor light environment is the dominant environment for most adults. What public health interventions follow, and what is the realistic scope of behavioral change?

6. The "circadian medicine" framework has produced both substantial research insights and substantial wellness-industry overclaim. How can the field move toward clearer communication about what is well-supported and what is hypothesis-generating?

7. Light therapy for SAD is one of the cleaner translational arcs in psychiatry — from syndrome discovery (Rosenthal 1984) through mechanism characterization to evidence-supported clinical intervention. What other circadian-related conditions might benefit from comparable clinical research investment?

Common Student Questions

Q: I work nights. Is my cancer risk really elevated? A: The IARC classified shift work involving circadian disruption as Group 2A (probably carcinogenic). The evidence is most consistent for breast cancer; less clear for other cancers. The mechanism is hypothesized (melatonin suppression, circadian disruption) but not definitively proven. The elevated risk in observational studies is modest in magnitude. If you work nights long-term, the framework supports reasonable consideration of mitigation strategies (regular sleep schedule even on off-days, attention to light environment, regular healthcare and screening) — but the framing should not be panic. The chapter teaches the science; clinical management belongs in conversation with your healthcare provider.

Q: Should I supplement vitamin D? A: The chapter doesn't prescribe. For individuals with documented vitamin D deficiency (25(OH)D <12 ng/mL in research definitions, with bone-health symptoms or other clinical context), supplementation is clearly appropriate and supported by both observational and trial evidence. For individuals with mild insufficiency (12-20 ng/mL) without specific clinical context, the case for supplementation is moderate. For individuals with adequate status (>20 ng/mL by IOM threshold), the VITAL trial findings argue against routine supplementation for cardiovascular and cancer prevention. The Endocrine Society 2024 update tempered earlier broader recommendations. Get your 25(OH)D measured if you're considering supplementation; clinical decisions belong in conversation with your healthcare provider who knows your specific context (skin pigmentation, geographic latitude, season, medical history, current medications).

Q: Do I need blue-light-blocking glasses? A: The evening short-wavelength light → melatonin suppression → circadian phase delay biology is real (Chang 2015 and similar). Whether consumer blue-light-blocking glasses replicate the laboratory effect adequately is methodologically less clear; commercial product specifications vary widely; effect sizes in real-world use are likely smaller than laboratory studies suggest. If you want to reduce evening short-wavelength light, simpler interventions (dim screens, less bright indoor lighting, less screen time before bed, shifted color spectra on devices) may be at least as effective as blue-light-blocking glasses with less consumer expense. The chapter takes the descriptive position: the biology is real, the consumer-product claims often exceed the research, the simpler interventions may be more cost-effective.

Q: I have SAD. Should I try light therapy? A: Light therapy for SAD is well-supported in published clinical research. Standard protocols use 10,000 lux for 30 minutes daily, morning timing, with appropriate equipment positioning. Clinical management of SAD belongs in conversation with a primary care provider or mental health clinician — the diagnosis itself warrants clinical evaluation, light therapy may be part of treatment, and other treatment modalities (SSRIs, psychotherapy, lifestyle interventions) may be appropriate alone or in combination. The chapter teaches the science of light therapy; clinical decisions about your specific situation belong in clinical conversations. If your symptoms are causing functional impairment, professional clinical evaluation is the appropriate next step.

Q: I'm a med student considering ophthalmology. How does this chapter fit? A: Ophthalmology training will cover the rod/cone phototransduction biology, the visual cortex pathways, and the principal retinal conditions at substantial depth. This chapter adds the non-image-forming photoreception (ipRGCs) and the circadian biology that ophthalmology occasionally encounters in pupillary light reflex testing and in certain retinal degenerations where ipRGC function is relatively preserved. The clinical translation of ipRGC biology to ophthalmology is still emerging — pupillary light reflex testing protocols using blue-light stimuli, for example, can assess M1 ipRGC function independently of rod/cone function. The chapter is foundational for the broader photobiology context; specific ophthalmology training adds the clinical and procedural depth.

Q: I read about "morning sunlight" and "view the sun" as Huberman recommendations. Should I do this? A: The underlying biology — morning outdoor light exposure supports circadian alignment through ipRGC-SCN pathways — is well-grounded. The wellness-industry shorthand "view the sun" is reframed throughout this chapter as "morning outdoor light exposure with appropriate eye care" — never direct sun-gazing, which can produce retinal damage. Morning outdoor activity (walking, sitting in natural light, exercise outdoors) provides substantial circadian benefit. Direct sun-gazing is dangerous and unnecessary. The biology supports the general framework; the specific implementation should not include practices that risk eye damage.

Q: What should I do about evening screens? A: Reduced evening short-wavelength light exposure likely supports better circadian timing in many adults. Practical interventions: dim screens in the evening; reduce screen time in the last 1-2 hours before sleep; consider color shifting (night mode on devices, while recognizing that warm color modes still produce some light exposure); ensure adequate morning daylight exposure (the most efficacious intervention may be increasing morning light rather than reducing evening light). The chapter does not prescribe specific protocols; the framework is research-informed but the personal implementation depends on your context.

Parent / Adult Family Communication Template

(Optional for instructors whose course communicates with adult family members.)

Subject: Coach Light — Bachelor's Level — Photobiology and Circadian Medicine

Dear Families,

This unit covers the Coach Light chapter at the Bachelor's degree level of the CryoCove Library — the eighth chapter of the upper-division undergraduate tier. The chapter goes substantially deeper than Associates: photobiology at molecular receptor depth, molecular clock at gene expression resolution, phase response curves and clinical chronotherapy, vitamin D biochemistry, and modern light environment pathophysiology.

Several notes you may want to know about:

• Clinical content is covered at research-grade depth — seasonal affective disorder and bright light therapy, vitamin D biology and the VITAL trial, shift work and the IARC cancer classification. All content is descriptive (mechanism and recognition) rather than diagnostic.
• Eye safety is maintained throughout — the chapter never recommends direct sun-gazing or tanning bed use.
• Vitamin D supplementation is routed to clinical conversation; the chapter teaches the biochemistry but defers specific decisions to clinical contexts.

If your student is considering light therapy, vitamin D supplementation, or other chronotherapy approaches, please encourage them to review the material with a healthcare provider.

With respect, The CryoCove Library Team

Resource Verification Note for Instructors

Crisis resources change. Re-verify the active status of the 988 Lifeline, Crisis Text Line (text HOME to 741741), and National Alliance for Eating Disorders helpline (866-662-1235) before each term you teach this chapter. The NEDA helpline (1-800-931-2237) was discontinued in 2023 and remains non-functional.

---

Illustration Briefs

Lesson 1 — ipRGCs and the Two Photoreceptive Systems

• Placement: After "The Berson 2002 Discovery of ipRGCs"
• Scene: A schematic mammalian retinal cross-section. Image-forming pathway (rods, cones → bipolar cells → ganglion cells → optic nerve → LGN → visual cortex). Non-image-forming pathway (M1-M5 ipRGCs with intrinsic melanopsin → SCN, OPN, dLGN). Wavelength sensitivity curves shown: rhodopsin peak ~498 nm, cone peaks 420/530/560 nm, melanopsin peak ~480 nm.
• Coach involvement: Coach Light (Rooster) at the side, with note: "Two systems, one retina, different timing."
• Mood: Foundational, integrative.
• Caption: "The retina sees more than images."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 2 — The BMAL1/CLOCK/PER/CRY TTFL

• Placement: After "The Mammalian TTFL at Gene Regulation Depth"
• Scene: A single cell schematic with nucleus and cytoplasm. In nucleus: BMAL1/CLOCK heterodimer at E-box driving Per and Cry transcription; mRNA exit. In cytoplasm: PER and CRY protein accumulation with CK1 phosphorylation; complex formation. Re-entry to nucleus: CRY-CLOCK/BMAL1 inhibition; FBXL3 ubiquitination of CRY in cytoplasm leading to degradation. Clock face overlay showing ~24 hour cycle.
• Coach involvement: Coach Light (Rooster) at the side, with note: "Every cell keeps time."
• Mood: Molecular, foundational.
• Caption: "Twenty-four hours, written in feedback."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 3 — The Human PRC to Light

• Placement: After "The Human PRC to Light: Khalsa 2003"
• Scene: A graph with circadian time on x-axis (24 hours), magnitude and direction of phase shift on y-axis. Curve showing phase delay zone (late evening through early morning, before core temperature minimum), phase advance zone (after core temperature minimum, late morning), and dead zone (afternoon, early evening). Marked: typical core temperature minimum at ~5 AM in entrained adult.
• Coach involvement: Coach Light (Rooster) at the side, with note: "Same light, different time, opposite direction."
• Mood: Methodological, clinical.
• Caption: "Timing is the message."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 4 — The Vitamin D Synthesis Cascade

• Placement: After "Vitamin D Synthesis: Cutaneous Through Renal"
• Scene: A schematic showing the synthesis pathway. Skin: 7-DHC + UVB → pre-vitamin D₃ → cholecalciferol; DBP transport to circulation. Liver: cholecalciferol + CYP2R1 → 25(OH)D. Kidney: 25(OH)D + CYP27B1 → 1,25(OH)₂D. Action: 1,25(OH)₂D + VDR-RXR → VDRE → calcium/phosphate target genes. Latitudinal/seasonal/skin pigmentation variables shown affecting cutaneous synthesis step.
• Coach involvement: Coach Light (Rooster) at the side, with note: "Sun on skin to gene expression in three steps."
• Mood: Biochemical, integrative.
• Caption: "Vitamin D is hormone, not vitamin."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 5 — Modern vs Natural Light Environment

• Placement: After "Wright Camping Studies: Natural-Light SCN Entrainment"
• Scene: Two parallel timeline graphics. Left: typical modern indoor lifestyle — limited bright morning light exposure, electric indoor light throughout day at 100-500 lux, evening electric light continuing past natural sunset, late melatonin onset, delayed sleep. Right: camping/natural light lifestyle — full bright daylight exposure during day, complete darkness after sunset (only campfire), early melatonin onset coupled to sunset, earlier sleep, naturally earlier wake. Below: chronotype variability reduced under camping conditions.
• Coach involvement: Coach Light (Rooster) at the side, with note: "Two light environments. Two different clocks."
• Mood: Comparative, ecological.
• Caption: "The modern indoor light environment is not the environment we evolved in."
• Aspect ratio: 16:9 web, 4:3 print

---

Citations

1. Berson DM. (2003). Strange vision: ganglion cells as circadian photoreceptors. Trends in Neurosciences, 26(6), 314-320.

2. Yau KW, Hardie RC. (2009). Phototransduction motifs and variations. Cell, 139(2), 246-264.

3. Lamb TD. (2009). Evolution of vertebrate retinal photoreception. Philosophical Transactions of the Royal Society B, 364(1531), 2911-2924.

4. Berson DM, Dunn FA, Takao M. (2002). Phototransduction by retinal ganglion cells that set the circadian clock. Science, 295(5557), 1070-1073. [Foundational anchor — ipRGC discovery.]

5. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. (2002). Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science, 295(5557), 1065-1070.

6. Schmidt TM, Chen SK, Hattar S. (2011). Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends in Neurosciences, 34(11), 572-580.

7. Quattrochi LE, Stabio ME, Kim I, et al. (2019). The M6 cell: a small-field bistratified photosensitive retinal ganglion cell. Journal of Comparative Neurology, 527(1), 297-311.

8. Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD. (2000). A novel human opsin in the inner retina. Journal of Neuroscience, 20(2), 600-605.

9. Mure LS, Cornut PL, Rieux C, et al. (2009). Melanopsin bistability: a fly's eye technology in the human retina. PLOS ONE, 4(6), e5991.

10. Takahashi JS. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews Genetics, 18(3), 164-179.

11. Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature, 418(6901), 935-941.

12. Konopka RJ, Benzer S. (1971). Clock mutants of Drosophila melanogaster. Proceedings of the National Academy of Sciences USA, 68(9), 2112-2116.

13. Hardin PE, Hall JC, Rosbash M. (1990). Feedback of the Drosophila period gene product on circadian cycling of its messenger RNA levels. Nature, 343(6258), 536-540.

14. Price JL, Blau J, Rothenfluh A, Abodeely M, Kloss B, Young MW. (1998). double-time is a novel Drosophila clock gene that regulates PERIOD protein accumulation. Cell, 94(1), 83-95.

15. King DP, Zhao Y, Sangoram AM, et al. (1997). Positional cloning of the mouse circadian Clock gene. Cell, 89(4), 641-653.

16. Vitaterna MH, King DP, Chang AM, et al. (1994). Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science, 264(5159), 719-725.

17. The Nobel Assembly at Karolinska Institutet. (2017). The Nobel Prize in Physiology or Medicine 2017: Jeffrey C. Hall, Michael Rosbash and Michael W. Young. Nobel Prize website.

18. Lowrey PL, Takahashi JS. (2011). Genetics of circadian rhythms in mammalian model organisms. Advances in Genetics, 74, 175-230.

19. Buhr ED, Takahashi JS. (2013). Molecular components of the mammalian circadian clock. Handbook of Experimental Pharmacology, 217, 3-27.

20. Godinho SI, Maywood ES, Shaw L, et al. (2007). The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science, 316(5826), 897-900.

21. Siepka SM, Yoo SH, Park J, et al. (2007). Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell, 129(5), 1011-1023.

22. Shigeyoshi Y, Taguchi K, Yamamoto S, et al. (1997). Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell, 91(7), 1043-1053.

23. Damiola F, Le Minh N, Berthet C, Schibler U. (2000). Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes & Development, 14(23), 2950-2961.

24. Stenvers DJ, Scheer FAJL, Schrauwen P, la Fleur SE, Kalsbeek A. (2019). Circadian clocks and insulin resistance. Nature Reviews Endocrinology, 15(2), 75-89.

25. Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. (2003). A phase response curve to single bright light pulses in human subjects. Journal of Physiology, 549(Pt 3), 945-952.

26. Chang AM, Aeschbach D, Duffy JF, Czeisler CA. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proceedings of the National Academy of Sciences USA, 112(4), 1232-1237.

27. Hester L, Dang D, Barker CJ, et al. (2021). Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International, 38(10), 1375-1383.

28. Singh S, Anderson AJ, Downie LE. (2019). Insights into Australian optometrists' knowledge and attitude towards prescribing blue light-blocking ophthalmic devices. Ophthalmic and Physiological Optics, 39(3), 194-204.

29. Straif K, Baan R, Grosse Y, et al. (2007). Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncology, 8(12), 1065-1066.

30. International Agency for Research on Cancer. (2020). IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 124: Night Shift Work. IARC, Lyon, France.

31. Eastman CI, Burgess HJ. (2009). How to travel the world without jet lag. Sleep Medicine Clinics, 4(2), 241-255.

32. Forbes-Robertson S, Dudley E, Vadgama P, Cook C, Drawer S, Kilduff L. (2012). Circadian disruption and remedial interventions: effects and interventions for jet lag for athletic peak performance. Sports Medicine, 42(3), 185-208.

33. Holick MF. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266-281.

34. Bouillon R, Carmeliet G. (2018). Vitamin D insufficiency: definition, diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism, 32(5), 669-684.

35. Pike JW, Meyer MB. (2010). The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D₃. Endocrinology and Metabolism Clinics of North America, 39(2), 255-269.

36. Carlberg C. (2019). Vitamin D signaling in the context of innate immunity: focus on human monocytes. Frontiers in Immunology, 10, 2211.

37. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. (2016). Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiological Reviews, 96(1), 365-408.

38. Bouillon R, Marcocci C, Carmeliet G, et al. (2019). Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine Reviews, 40(4), 1109-1151.

39. Webb AR. (2006). Who, what, where and when — influences on cutaneous vitamin D synthesis. Progress in Biophysics and Molecular Biology, 92(1), 17-25.

40. Holick MF. (2008). Vitamin D: a D-Lightful health perspective. Nutrition Reviews, 66(10 Suppl 2), S182-S194.

41. Institute of Medicine. (2011). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, DC.

42. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96(7), 1911-1930.

43. Demay MB, Pittas AG, Bikle DD, et al. (2024). Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 109(8), 1907-1947.

44. Manson JE, Cook NR, Lee IM, et al. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380(1), 33-44.

45. Rosenthal NE, Sack DA, Gillin JC, et al. (1984). Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry, 41(1), 72-80.

46. Lam RW, Levitt AJ, Levitan RD, et al. (2016). Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry, 73(1), 56-63.

47. Terman M, Terman JS. (2005). Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectrums, 10(8), 647-663.

48. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. (2006). The circadian basis of winter depression. Proceedings of the National Academy of Sciences USA, 103(19), 7414-7419.

49. Avery DH, Eder DN, Bolte MA, et al. (2001). Dawn simulation and bright light in the treatment of SAD: a controlled study. Biological Psychiatry, 50(3), 205-216.

50. Danilenko KV, Plisov IL, Hébert M, Krämer A, Wirz-Justice A. (2003). Influence of timed nutrient diet on depression and light sensitivity in seasonal affective disorder. Chronobiology International, 25(1), 51-64.

51. Wright KP Jr, McHill AW, Birks BR, Griffin BR, Rusterholz T, Chinoy ED. (2013). Entrainment of the human circadian clock to the natural light-dark cycle. Current Biology, 23(16), 1554-1558.

52. Stothard ER, McHill AW, Depner CM, et al. (2017). Circadian entrainment to the natural light-dark cycle across seasons and the weekend. Current Biology, 27(4), 508-513.

53. Roenneberg T, Wirz-Justice A, Merrow M. (2003). Life between clocks: daily temporal patterns of human chronotypes. Journal of Biological Rhythms, 18(1), 80-90.

54. Wittmann M, Dinich J, Merrow M, Roenneberg T. (2006). Social jetlag: misalignment of biological and social time. Chronobiology International, 23(1-2), 497-509.

55. Skene DJ, Arendt J. (2006). Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Annals of Clinical Biochemistry, 43(Pt 5), 344-353.

56. Lockley SW, Brainard GC, Czeisler CA. (2003). High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. Journal of Clinical Endocrinology and Metabolism, 88(9), 4502-4505.

57. Gooley JJ, Chamberlain K, Smith KA, et al. (2011). Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. Journal of Clinical Endocrinology and Metabolism, 96(3), E463-E472.

58. Brainard GC, Hanifin JP, Greeson JM, et al. (2001). Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. Journal of Neuroscience, 21(16), 6405-6412.

59. Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. Journal of Physiology, 535(Pt 1), 261-267.

60. Czeisler CA, Duffy JF, Shanahan TL, et al. (1999). Stability, precision, and near-24-hour period of the human circadian pacemaker. Science, 284(5423), 2177-2181.

61. Czeisler CA, Khalsa SB. (2000). The human circadian timing system and sleep-wake regulation. Principles and Practice of Sleep Medicine (3rd ed.). Saunders, Philadelphia.

62. Cajochen C, Münch M, Kobialka S, et al. (2005). High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. Journal of Clinical Endocrinology and Metabolism, 90(3), 1311-1316.

63. Holick MF. (2017). The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders, 18(2), 153-165.

64. Webb AR, Kazantzidis A, Kift RC, Farrar MD, Wilkinson J, Rhodes LE. (2018). Meeting vitamin D requirements in white Caucasians at UK latitudes: providing a choice. Nutrients, 10(4), 497.

65. Pittas AG, Dawson-Hughes B, Sheehan P, et al. (2019). Vitamin D supplementation and prevention of type 2 diabetes. New England Journal of Medicine, 381(6), 520-530.

66. Scragg R, Stewart AW, Waayer D, et al. (2017). Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial. JAMA Cardiology, 2(6), 608-616.

67. LeFevre ML; U.S. Preventive Services Task Force. (2015). Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 162(2), 133-140.

68. Burgess HJ, Crowley SJ, Gazda CJ, Fogg LF, Eastman CI. (2003). Preflight adjustment to eastward travel: 3 days of advancing sleep with and without morning bright light. Journal of Biological Rhythms, 18(4), 318-328.

69. Lockley SW. (2009). Safety considerations for the use of blue-light blocking glasses in shift-workers. Sleep Medicine, 10(3), 287-288.

70. Crowley SJ, Lee C, Tseng CY, Fogg LF, Eastman CI. (2003). Combinations of bright light, scheduled dark, sunglasses, and melatonin to facilitate circadian entrainment to night shift work. Journal of Biological Rhythms, 18(6), 513-523.

71. Erren TC, Reiter RJ. (2009). Defining chronodisruption. Journal of Pineal Research, 46(3), 245-247.

72. Reiter RJ, Tan DX, Korkmaz A, et al. (2012). Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Critical Reviews in Oncogenesis, 13(4), 303-328.

73. Hansen J. (2017). Night shift work and risk of breast cancer. Current Environmental Health Reports, 4(3), 325-339.

74. Travis RC, Balkwill A, Fensom GK, et al. (2016). Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. Journal of the National Cancer Institute, 108(12), djw169.

75. Hattar S, Lucas RJ, Mrosovsky N, et al. (2003). Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature, 424(6944), 76-81.

76. LeGates TA, Fernandez DC, Hattar S. (2014). Light as a central modulator of circadian rhythms, sleep and affect. Nature Reviews Neuroscience, 15(7), 443-454.

77. Lazzerini Ospri L, Prusky G, Hattar S. (2017). Mood, the circadian system, and melanopsin retinal ganglion cells. Annual Review of Neuroscience, 40, 539-556.

78. Eastman CI, Burgess HJ. (2009). How to travel the world without jet lag. Sleep Medicine Clinics, 4(2), 241-255.

79. Phillips AJK, Vidafar P, Burns AC, et al. (2019). High sensitivity and interindividual variability in the response of the human circadian system to evening light. Proceedings of the National Academy of Sciences USA, 116(24), 12019-12024.

80. Burgess HJ, Park M, Wyatt JK, Fogg LF. (2015). Home dim light melatonin onsets with measures of compliance in delayed sleep phase disorder. Journal of Sleep Research, 24(6), 651-657.

81. Roenneberg T, Allebrandt KV, Merrow M, Vetter C. (2012). Social jetlag and obesity. Current Biology, 22(10), 939-943.

82. Lewy AJ, Sack RL, Singer CM, White DM. (1987). The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence. Psychopharmacology Bulletin, 23(3), 349-353.